Skip to Content

A318 (Fenofibrate (Micronized) 134 mg)

Pill with imprint A318 is White, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Alembic Pharmaceuticals Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A318

Fenofibrate (Micronized)

Imprint
A318
Strength
134 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
National Drug Code (NDC)
62332-0085

Get help with Imprint Code FAQs.

Related Images for "A318"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.